- Investing Ideas
- U.S. Pharmaceuticals & Biotech Upcoming Dividends
U.S. Pharmaceuticals & Biotech Upcoming Dividends
Results
8
Companies which have announced upcoming dividend payments.
8 companies
Bristol-Myers Squibb
Market Cap: US$123.7b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
US$58.22
7D
-0.8%
1Y
15.1%
Johnson & Johnson
Market Cap: US$553.3b
Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.
JNJ
US$227.19
7D
-0.1%
1Y
45.5%
Zoetis
Market Cap: US$48.3b
Engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.
ZTS
US$114.16
7D
-2.3%
1Y
-27.5%
Amgen
Market Cap: US$186.9b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$329.82
7D
-4.3%
1Y
17.3%
AbbVie
Market Cap: US$373.8b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$206.60
7D
4.0%
1Y
4.1%
Pfizer
Market Cap: US$151.9b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
US$26.33
7D
-2.5%
1Y
8.8%
Perrigo
Market Cap: US$1.6b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PRGO
US$11.92
7D
0.8%
1Y
-53.5%
Royalty Pharma
Market Cap: US$29.7b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$49.47
7D
0.2%
1Y
50.4%